Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Werewolf Therapeutics Inc (NQ: HOWL ) 2.030 +0.020 (+1.00%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Werewolf Therapeutics Inc < Previous 1 2 3 4 Next > Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session November 03, 2023 Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740. Via Benzinga Delta Air Lines Layoffs 2023: What to Know About the Latest DAL Job Cuts November 03, 2023 Delta Air Lines layoffs have the air travel company announcing minor adjustments to its corporate and management positions. Via InvestorPlace Topics Workforce Exposures Layoff Expert Ratings for Werewolf Therapeutics May 11, 2023 Via Benzinga Recap: Werewolf Therapeutics Q1 Earnings May 11, 2023 Via Benzinga Analyst Ratings for Werewolf Therapeutics March 24, 2023 Via Benzinga CVNA Stock Alert: What Analysts Are Saying After Carvana’s Q3 Earnings November 03, 2023 Carvana stock is on the move as analysts weigh in on CVNA shares following the release of the company's latest earnings report. Via InvestorPlace Why Is Werewolf Therapeutics (HOWL) Stock Up 20% Today? November 03, 2023 Werewolf Therapeutics stock is taking off with heavy trading of HOWL shares after posting preliminary data from a clinical trial. Via InvestorPlace Werewolf Therapeutics' Cancer Drug Shows Promise in Early Study for Solid Tumors, Stock Soars November 03, 2023 Werewolf Therapeutics Inc (NASDAQ: HOWL) released preliminary results from initial monotherapy dose-escalation cohorts of an ongoing Phase 1/1b trial of WTX-124 in patients with advanced or Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session November 03, 2023 Via Benzinga Werewolf Therapeutics Presents Preliminary Monotherapy Data from Phase 1/1b Clinical Trial Establishing Proof of Mechanism for WTX-124 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting November 03, 2023 From Werewolf Therapeutics, Inc. Via GlobeNewswire Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session November 02, 2023 Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. Via Benzinga Why Roku Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket November 02, 2023 Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 39.7% to $0.1143 in pre-market trading after falling 17% on Wednesday. LumiraDX recently announced the receipt of the Nasdaq delisting... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 02, 2023 Pre-market stock movers are a hot topic on Thursday and we're checking out all of the biggest ones worth watching this morning! Via InvestorPlace Werewolf Therapeutics to Present Clinical and Preclinical Data at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting October 31, 2023 From Werewolf Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session October 25, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday October 12, 2023 Pre-market stock movers are a hot topic among traders on Thursday and we're offering all of the latest coverage this morning! Via InvestorPlace Werewolf Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting September 27, 2023 From Werewolf Therapeutics, Inc. Via GlobeNewswire Werewolf Therapeutics to Host KOL Event Highlighting IL-2 Landscape and Opportunity for WTX-124 September 11, 2023 Virtual event to be held on Monday, September 18, 2023, at 10:00 am ET From Werewolf Therapeutics, Inc. Via GlobeNewswire Werewolf Therapeutics to Participate in Upcoming Investor Conferences September 05, 2023 From Werewolf Therapeutics, Inc. Via GlobeNewswire Small Cancer Player Werewolf Therapeutics' Stock Undervalued: Analyst Says Treatment Platform Underappreciated August 24, 2023 Wedbush initiated coverage on Werewolf Therapeutics Inc (NASDAQ: HOWL) with an Outperform rating and a Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session August 24, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2023 August 24, 2023 Via Benzinga Werewolf Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update August 10, 2023 From Werewolf Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 08, 2023 Via Benzinga Werewolf Therapeutics to Present at the Jefferies Healthcare Conference June 01, 2023 From Werewolf Therapeutics, Inc. Via GlobeNewswire Werewolf Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update May 11, 2023 From Werewolf Therapeutics, Inc. Via GlobeNewswire Werewolf Therapeutics to Participate in May Investor Conferences May 01, 2023 From Werewolf Therapeutics, Inc. Via GlobeNewswire Werewolf Therapeutics Publishes Preclinical Data on mWTX-330, an IL-12 INDUKINE™ Molecule, in Cancer Immunology Research April 19, 2023 From Werewolf Therapeutics, Inc. Via GlobeNewswire Werewolf Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update March 23, 2023 From Werewolf Therapeutics, Inc. Via GlobeNewswire UPDATE -- Werewolf Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2023 March 16, 2023 From Werewolf Therapeutics, Inc. Via GlobeNewswire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.